Best Practices in Responsible Opioid Prescribing & Dispensing: A Healthcare Provider Training Series
January 8, 2016
Objective: As a result of participating in this activity, the attendee should be able to: Evaluate abuse-deterrent technologies associated with opioid therapy and evidence-based literature for patient-related factors associated with risk of relapse if opioid medications are used to treat pain in patients with a history of addiction; Formulate a response to challenges encountered in the management of chronic pain in patients at risk for, or with a history of, addiction; Describe the principles of universal precautions used as the standard of care in prescribing controlled substances and then apply concepts of universal precaution to situations in everyday practice situations; Assess patients for the risk of drug misuse, abuse, or addictions, and assign a level of risk to each patient; Explain the rationale and effectiveness of buprenorphine and methadone maintenance therapy in the outpatient treatment of opioid dependence and then be able to contract the safety profiles of buprenorphine and methadone used in outpatient treatment of opioid dependence; Describe the components and role of non-pharmacological treatment of opioid dependence and apply clinical tools (e.g. Treatment agreement, urine drug screens, pill counts, etc.) needed for an effective outpatient treatment program; Review the history of the development, initiation and utilization of the PMP in Virginia, and then be able to explain the goals of the PMP; Demonstrate how to use the PMP as a resource in patient-centered care; and Evaluate a PMP report and develop a plan of action to use in the clinical setting.
Target Audience: Phys(Fam, Int, Ob, Ped, Psych, Surg, EM), Dentists, APNS, PAs, NPs, Pharms, Psychs, RNs, LPNs, Dental Hygienists
Credits Offered: AMA PRA Category 1 Credits™ - 4.00; Attendance Credit - 4.00